Immunotherapy in patients with advanced cancer breast
AJM-Alexandria Journal of Medicine Journal Country: Egypt
P-ISSN: 1110-0834
MeSH Terms: / Therapy
Broad Subjects: Noncommunicable Diseases, Immunotherapy ,
Citation: M. S. El Kilany, Immunotherapy in patients with advanced cancer breast. Bull. Alex. Fac. Med. 1986; 22 (1): 47-56
Studies of the use of immunotherapy as an adjuvant modality in the multimodal treatment [RICH regime] of breast cancer indicated that it had a promising and strong effect. Immunotherapy alone is difficult to act, as it acts on a small number of tumor cell, thus, it should be used with other cytoreductive modalities. Patients receiving immunotherapy [lethally irradiated autografts from cancer cells and levamisole] showed improvement in humoral and cell-mediated immunity, recurrence-free interval and survival time after mastectomy. Immunotherapy, by the manner described in this work, is simple and well tolerated and leads us to advice its use on a wider scale
